LC determination of ritonavir, a HIV protease inhibitor, in soft gelatin capsules

Chromatographia

Volumn 62, Issue 11-12, 2005, Pages 589-593

  Dias, C L ^a   Rossi, R C ^a   Donato, E M ^a   Bergold, A M ^a   Froehlich P E ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Column liquid chromatography; Photodiode array detection; Ritonavir in soft gelatin capsules

Indexed keywords

AMINE; CARBON; GELATIN; METHANOL; PROTEINASE INHIBITOR; RITONAVIR; WATER;

ANALYTIC METHOD; ANTENNA; ARTICLE; CALIBRATION; DIAGNOSTIC ACCURACY; DIODE LASER; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PARTICLE SIZE; PLOTS AND CURVES; PRIORITY JOURNAL; STATISTICAL ANALYSIS; ULTRAVIOLET RADIATION;

EID: 29144449189     PISSN: 00095893     EISSN: 16121112     Source Type: Journal    
DOI: 10.1365/s10337-005-0670-0     Document Type: Article

References (40)

1. Sethi ML (2002) Antiviral Agents and Protease Inhibitors. In: Foye's Principles of Medicinal Chemistry, Williams DA, Lemke TL, Philadelphia
2. Tavares W (1996) Manual de Antibióticos e Quimioterápicos Antiinfecciosos, São Paulo
3. Raffanti S, Haas DW (2001) Antimicrobial Agents-Antiretroviral Agents. In: Goodman & Gilman's The Pharmacological Basis of Therapeutics, Hardman JG, Limbird LE (eds) Gilman AG, USA
4. Abbott Laboratories, Norvir® (ritonavir capsules) Soft Gelatin / (ritonavir oral solution). North Chicago, IL 60064, U.S.A., Ref.: 03-5409-R20, Revised: January, 2005: http://www.norvir.com/pdf/norpi2a.PDF
5. Chen X, Kempf DJ, Li L, Sham HL, Vasavanonda S, Wideburg NE, Saldivar A, Marsh KC, McDonald E, Norbeck DW (2003) Bioorg Med Chem Lett 13:3657-3660
6. Korolkovas A (2004) Dicionário Terapêutico Guanabara, Rio de Janeiro
7. Murphy RL (2003) J Acquir Immune Defic Syndr 33:S33-S56.
8. FDA, HIV/AIDS Timeline Chronology of Significant Events, September, 2004: http://www.fda.gov/oashi/aids/miles.html
9. O'Neil MJ, Smith A, Heckelman PE, Budavari S (eds) (2001) The Merck Index: An Encyclopedia of Chemicals, Drugs & Biologicals, Whitehouse Station, NJ
10. Marsh KC, Eiden E, McDonald E (1997) J Chromatogr B Biomed Sci Appl 704:307-313
11. Hoetelmans RM, van Essenberg M, Profijt M, Meenhorst PL, Mulder JW, Beijnen JH (1998) J Chromatogr B Biomed Sci Appl 705:119-126
12. Frappier S, Breilh D, Diart E, Ba B, Ducint D, Pellegrin JL, Saux MC (1998) J Chromatogr B Biomed Sci Appl 714:384-389. DOI: 10.1016/s0378-4347(98) 00220-5
13. Marzolini C, Telenti A, Buclin T, Biollaz J, Decosterd LA (2000) J Chromatogr B Biomed Sci Appl 740:43-58. DOI: 10.1016/ s0378-4347(99)00573-3
14. Dailly E, Thomas L, Kergueris MF, Jolliet P, Bourin M (2001) J Chromatogr B Biomed Sci Appl 758:129-135. DOI: 10.1016/s0378-4347(01)00117-7
15. Sarasa-Nacenta M, López-Púa Y, Mallolas J, Blanco JL, Gatell JM, Carné X (2001) J Chromatogr B Biomed Sci Appl 757:325-332. DOI: 10.1016/s0378-4347(01)00172-4
16. Yamada H, Kotaki H, Nakamura T, Iwamoto A (2001) J Chromatogr B Biomed Sci Appl 755:85-89. DOI: 10.1016/s0378-4347(00)00617-4
17. Leibenguth P, Le Guellec C, Besnier JM, Bastides F, Macé M, Gaudet ML, Autret-Leca E, Paintaud G (2001) Ther Drug Monit 23:679-688
18. Simon VA, Thiam MD, Lipford LC (2001) J Chromatogr A 913:447-453. DOI: 10.1016/s0021-9673(00)01092-x
19. Villani P, Feroggio M, Gianelli L, Bártoli A, Montagna M, Maserati R, Regazzi MB (2001) Ther Drug Monit 23:380-388
20. Volosov A, Napoli KL, Soldin SJ (2001) Clin Biochem 34:285-290
21. Janoly A, Beyzac N, Favetta P, Gagneu MC, Bourhis Y, Coudray S, Oger I, Aulagner G (2002) J Chromatogr B Biomed Sci Appl 780:155-160
22. Ray J, Pang E, Carey D (2002) J Chromatogr B Biomed Sci Appl 775:225-230
23. Marzolini C, Béguin A, Telenti A, Schreyer A, Buclin T, Biollaz J, Decosterd LA (2002) J Chromatogr B Biomed Sci Appl 774:127-140. DOI: 10.1016/s1570-0232(02)00169-1
24. Titier K, Lagrange F, Péhourcq F, Edno-Mcheik L, Moore N, Molimard M (2002) Therapie 57:169-174
25. Tribut O, Arvieux C, Michelet C, Chapplain JM, Allain H, Bentue-Ferrer D (2002) Ther Drug Monit 24:554-562. DOI: 10.1097/01.FTD.0000017718.61918.93
26. Poirier JM, Robidou P, Jaillon P (2002) Ther Drug Monit 24:302-309
27. Chi JD, Jayewardene AL, Stone JA, Motoya T, Aweeka FT (2002) J Pharm Biomed Anal 30:675-684
28. Turner ML, Reed-Walker K, King JR, Acosta EP (2003) J Chromatogr B Biomed Sci Appl 784:331-341
29. Justesen US, Pedersen C, Klitgaard NA (2003) J Chromatogr B Biomed Sci Appl 783:491-500
30. Faux J, Venisse N, Le Moal G, Dupuis A, Bouquet S (2003) Chromatographia 58:421-426. DOI: 10.1365/s10337-003-0076-90009-5893/03/10
31. Droste JAH, Verweij-van Wissen CPWGM, D.M. Burger DM (2003) Ther Drug Monit 25:393-399
32. Walson PD, Cox S, Utkin I, Gerber N, Crim L, Brady M, Koranyi K (2003) Ther Drug Monit 25: 588-592
33. Frerichs VA, DiFrancesco R, Morse GD (2003) J Chromatogr B Biomed Sci Appl 787:393-403
34. Rentsch KM (2003) J Chromatogr B Biomed Sci Appl 788:339-350
35. th (2005), Rockville, MD
36. ICH (1994) Harmonised Tripartite Guideline, Text on Validation of Analytical Procedures, Q2A. In: International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use
37. ICH (1996) Harmonised Tripartite Guideline, Validation of Analytical Procedures: Methodology, Q2B. In: International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use
38. FDA (1994) Center for Drug Evaluation and Research. Reviewer Guidance: Validation of Chromatographic Methods, Rockville, MD
39. Bakshi M, Singh S (2002) J Pharm Biomed Anal 28:1011-1040
40. Rowe RC, Sheskey PJ, Weller PJ (eds) (2000) Handbook of Pharmaceutical Excipients, Washington